ADAPTIVE BIOTECHNOLOGIES CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$184.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$184.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$281.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $42.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $138.00K, a 79.68% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $87.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$49.00K, a 101.13% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $4.33M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$2.98M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$184.00K 10-Q · filed 2026-08-04 | -$465.00K 10-Q · filed 2026-08-04 | -$423.00K derived: sum of 3 quarters · filed 2026-08-04 | -$285.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$281.00K 10-Q · filed 2026-05-05 | -$239.00K derived: sum of 2 quarters · filed 2026-05-05 | -$101.00K derived: sum of 3 quarters · filed 2026-05-05 | -$162.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $180.00K derived: sum of 2 quarters · filed 2026-02-26 | $119.00K derived: sum of 3 quarters · filed 2026-08-04 | $87.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $138.00K 10-Q · filed 2025-11-05 | $77.00K derived: sum of 2 quarters · filed 2026-08-04 | $45.00K 10-Q · filed 2025-11-05 | -$286.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$61.00K 10-Q · filed 2026-08-04 | -$93.00K 10-Q · filed 2026-08-04 | -$424.00K derived: sum of 3 quarters · filed 2026-08-04 | $255.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$32.00K 10-Q · filed 2026-05-05 | -$363.00K derived: sum of 2 quarters · filed 2026-05-05 | $316.00K derived: sum of 3 quarters · filed 2026-05-05 | $240.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $348.00K derived: sum of 2 quarters · filed 2026-02-26 | $272.00K derived: sum of 3 quarters · filed 2026-02-26 | -$49.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $679.00K 10-Q · filed 2025-11-05 | $603.00K derived: sum of 2 quarters · filed 2025-11-05 | $282.00K 10-Q · filed 2025-11-05 | $747.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$76.00K 10-Q · filed 2025-08-05 | -$397.00K 10-Q · filed 2025-08-05 | $68.00K derived: sum of 3 quarters · filed 2026-02-26 | $711.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$321.00K 10-Q · filed 2025-05-01 | $144.00K derived: sum of 2 quarters · filed 2026-02-26 | $787.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.11M derived: sum of 2 quarters · filed 2026-02-26 | $2.12M derived: sum of 3 quarters · filed 2026-02-26 | $4.33M 10-K · filed 2026-02-26 |
| 2023-09-30 | $643.00K 10-Q · filed 2024-11-07 | $1.66M derived: sum of 2 quarters · filed 2024-11-07 | $3.87M 10-Q · filed 2024-11-07 | $5.72M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $1.01M 10-Q · filed 2024-08-01 | $3.22M 10-Q · filed 2024-08-01 | $5.08M derived: sum of 3 quarters · filed 2025-03-03 | $4.91M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $2.21M 10-Q · filed 2024-05-07 | $4.07M derived: sum of 2 quarters · filed 2025-03-03 | $3.90M derived: sum of 3 quarters · filed 2025-03-03 | $2.88M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.68M derived: sum of 2 quarters · filed 2025-03-03 | $667.00K derived: sum of 3 quarters · filed 2025-03-03 | -$2.98M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$171.00K 10-Q · filed 2023-11-09 | -$1.19M derived: sum of 2 quarters · filed 2023-11-09 | -$4.83M 10-Q · filed 2023-11-09 | -$5.98M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$1.02M 10-Q · filed 2023-08-02 | -$4.66M 10-Q · filed 2023-08-02 | -$5.81M derived: sum of 3 quarters · filed 2024-02-29 | -$6.02M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$3.65M 10-Q · filed 2023-05-03 | -$4.79M derived: sum of 2 quarters · filed 2024-02-29 | -$5.00M derived: sum of 3 quarters · filed 2024-02-29 | -$5.41M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.35M derived: sum of 2 quarters · filed 2024-02-29 | -$1.77M derived: sum of 3 quarters · filed 2024-02-29 | -$2.03M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$209.00K 10-Q · filed 2022-11-03 | -$624.00K derived: sum of 2 quarters · filed 2022-11-03 | -$886.00K 10-Q · filed 2022-11-03 | -$1.42M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$415.00K 10-Q · filed 2022-08-03 | -$677.00K 10-Q · filed 2022-08-03 | -$1.21M derived: sum of 3 quarters · filed 2023-02-14 | -$1.94M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$262.00K 10-Q · filed 2022-05-04 | -$796.00K derived: sum of 2 quarters · filed 2023-02-14 | -$1.52M derived: sum of 3 quarters · filed 2023-02-14 | -$2.68M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$1.26M derived: sum of 2 quarters · filed 2023-02-14 | -$2.42M derived: sum of 3 quarters · filed 2023-02-14 | $222.00K 10-K · filed 2023-02-14 |
| 2020-09-30 | -$726.00K 10-Q · filed 2021-11-03 | -$1.89M derived: sum of 2 quarters · filed 2021-11-03 | $756.00K 10-Q · filed 2021-11-03 | $855.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$1.16M 10-Q · filed 2021-08-04 | $1.48M 10-Q · filed 2021-08-04 | $1.58M derived: sum of 3 quarters · filed 2022-02-15 | $1.77M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.64M 10-Q · filed 2021-05-05 | $2.74M derived: sum of 2 quarters · filed 2022-02-15 | $2.93M derived: sum of 3 quarters · filed 2022-02-15 | $3.22M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $289.00K derived: sum of 2 quarters · filed 2022-02-15 | $579.00K derived: sum of 3 quarters · filed 2022-02-15 | $778.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | $190.00K 10-Q · filed 2020-11-10 | $480.00K derived: sum of 2 quarters · filed 2020-11-10 | $679.00K 10-Q · filed 2020-11-10 | $773.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $290.00K 10-Q · filed 2020-08-10 | $489.00K 10-Q · filed 2020-08-10 | $583.00K derived: sum of 3 quarters · filed 2021-02-24 | $622.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $199.00K 10-Q · filed 2020-05-12 | $293.00K derived: sum of 2 quarters · filed 2021-02-24 | $332.00K derived: sum of 3 quarters · filed 2021-02-24 | $375.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $133.00K derived: sum of 2 quarters · filed 2021-02-24 | $176.00K derived: sum of 3 quarters · filed 2021-02-24 | $59.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $39.00K 10-Q · filed 2019-11-12 | $82.00K derived: sum of 2 quarters · filed 2019-11-12 | -$35.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $43.00K 10-Q · filed 2019-08-13 | -$74.00K 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | -$84.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |